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Background: Infections remain a serious compLi- 
cation in patients undergoing aLLogeneic stem ceLL 
TranspLantation. We sought to determine spectrum 
of infections in CBST recipients at our institution. 
Methods: This retrospective analysis was per- 
formed after obtaining approval from Institutional 
Review Board. Records of aLL 97 recipients of 
CBST were evaluated using a standardized data 
retrieval mechanism. ALL values are presented as 
median+s.d. 
Results: Among 59 pediatric and 38 adult pa- 
tients age was 74-5 years and 334-12 years, respec- 
tively. Ninety-four (97%) of 97 patients had under- 
Lying hematologic malignancy, acute Lymphocytic 
Leukemia was common (40 [43%] of 94) foLLowed 
by acute myeLogenous Leukemia (26 [28%] of 94). 
Myetoabtative conditioning regimen was given in 
40 (40%) patients; engraftment occurred 244-9 days 
foLLowing transplant. In 20 patients (21%) failure 
was either due to primary non-engraftment or 
refractory Leukemia. Seventy percent had graft- 
versus-host-diseases (GVHD), median time from 
transplantation and diagnosis of GVHD was 184-39 
post-CBSCT days. The infections complications are 
shown in the table below. The overaLL mortality 
was 66% foLLowin g CBST (median 1474-214 days and 
range, 10 to 993 days), in 20 (31%) of 64 patients 
who died, death was associated with an infection- 
related complication. 
Conclusions: InterestingLy, nearly a quarter of sys- 
temic bacterial and viral infections were noted 
after 100 days post-transpLantation. Whereas, most 
systemic funga[ infections in these severely im- 
munosuppressed patients including those with 
GVHD occurred within 30 days of receiving 
unreLated-donor CBST. 
Episode type Days Fo[[owin 8 CBSCT 
0-30 31-100 100 Overall 
54 (19) 19 (7) 21 (7) 94 (33) 
31 (11) 35 (12) 25 (9) 91 (32) 
12 (4) 11 (4) I (0.5) 24 (9) 
26 (9) 8 (3) 5 (2) 39 (14) 
8 (3) 1 (0.5) 1 (0.5) 10 (4) 
0 (0) 3 (1) 1 (0.5) 4 (2) 
8 (3) 5 (2) 6 (2) 19 (7) 
139 (49) 82 (29) 60 (21) 281 (100) 
aCDl: CLinicaL document infections. 
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Eicosanoid Regulation of Host Defense Post-Bone 
Marrow Transplantation 
M.N. BaLLinger*, D.M. Aronoff, T.R. McMNian, 
K.R. Cooke, M. Peters-GoLden, B.B. Moore. 
Immunology Program, University o[ Michigan, Ann 
Arbor, 441, USA 
Background: Bone marrow transplantation (BMT) 
is a treatment of choice for various malignant and 
inherited disorders. UnfortunateLy, this therapy is 
plagued by numerous pulmonary complications. 
Infections by the Gram-negative bacteria Pseu- 
domonas aeruginosa have emerged as a Leading 
cause of nosocomia[ pneumonia post-BMT. We have 
previously shown that mice receiving a syngeneic 
BMT are more susceptible to P. aeruginosa infec- 
tions in vivo. We have shown that the increased 
susceptibility of BMT mice is due to defective 
phagocytosis by the aLveoLar macrophages (AMs) 
and an inability of these ceLLs to produce activating 
cytokines, such as TNF-aLpha. Previous work has 
shown that eicosanoids, ceLL-secreted Lipid medi- 
ators, have an important role in the regulation of 
innate immunity. InterestingLy, BMT patients have 
increased LeveLs of circulating prostagLandin E2 
(PGE2), a negative regulator of the innate immune 
system, in their plasma for weeks to months post- 
transplant. 
Objective: Our hypothesis is that altered synthesis 
of eicosanoids contributes to immunosuppression 
post-BMT. 
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Methods: Recipient C57Bt/6 mice received 13Gy 
of totat body irradiation and were rescued with BM 
obtained from femurs of donor C57Bt/6 mice. Res- 
ident AMs and recruited tung PMNs were harvested 
3 to 5 weeks post-BMT and their eicosanoid profite 
were examined. We measured the Fc and non-Fc 
mediated phagocytosis and kitting of AMs and PMNs 
post-BMT. Indomethacin, a PG inhibitor, was used 
to brock PGE2 production in vitro and in vivo. 
Results: BMT AMs produce 125-times more PGE2 
than controt AMs and BMT PMNs produce 27-ford 
more PGE2 than controt PMNs. We have shown that 
the increased susceptibitity of BMT mice corretates 
with defective AM phagocytosis and kitting of Gram- 
negative bacteria. Interestingty, PMNs from BMT 
mice do not disptay defective phagocytosis, but 
do show a defect in their abitity to kitt ingested 
Gram-negative bacteria. The pharmacotogic btock- 
ade of prostagtandin production by indomethacin in 
vitro restores AM phagocytosis and kitting and PMN 
kitting. In addition, treatment with indomethacin 
restores host defense to P. aeruginosa in vivo. 
Conclusions: We show that eicosanoid dysregu- 
ration post-BMT inhibits the effectiveness of the 
innate immune response. Inhibiting PGs in vitro and 
in vivo restores impaired putmonary host defense 
post-BMT. 
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University of Michigan, Ann Arbor, MI, USA 
Background: Bone marrow transptantation (BMT) 
is used in the treatment of various matignan- 
cies. The success of BMT is timited by muttipte 
comptications inctuding putmonary infections both 
pre-engraftment and after engraftment has oc- 
curred. We previousty demonstrated that mice af- 
ter BMT have an increased susceptibitity to Gram- 
negative bacteriat pneumonia after engraftment. 
This appears to be due to impaired tung innate 
immunity with defective phagocytosis in atveo- 
tar macrophages, and defective kitting in tung 
neutrophits. Response to vaccination is dimin- 
ished in patients post-BMT indicating that there 
are adaptive immune defects as wett. To fur- 
ther etucidate the adaptive immune defects in 
rungs post-BMT, we anatyzed a tung infection with 
muMne gammaherpesvirus-68 (MHV-68). MHV-68 is 
a ds-DNA virus that is most simitar to Epstein 
Barr virus (EBV) and Kaposi sarcoma-associated 
herpesvirus (KSHV) in humans. 
Objective: Our hypothesis is that dysregutation in 
the adaptive immune response in the rungs post- 
BMT reads to increased susceptibitity to virat in- 
fection. 
Methods: Syngeneic BMT was performed in recip- 
ient C57Bt/6 mice receiving 13Gy of totat body 
irradiation, rescued with bone marrow obtained 
from the femurs of donor C57Bt/6 mice. Con- 
trot (untransptanted) and BMT mice were infected 
with 5x104 ptaque forming units (PFUs) MHV-68 
intranasatty at 6 weeks post-BMT. PFUs were mea- 
sured from tung homogenates at days 3, 5, 7, 9, 
and 14 post-infection. Cett counts and differentiats 
were performed and tymphocyte subsets were an- 
atyzed with flow cytometry. Cytokine revers were 
measured using ELISA. 
Results: Mice that have undergone BMT have 25- 
times the PFUs at day 7 post-infection versus con- 
trot mice. There is an increase in the percentage 
of neutrophits, and a decrease in tymphocytes in 
BMT mice versus controt mice. There is a decrease 
in the percentage of CD8+ T-cetts, but no change 
in CD4+ T-cetts, B-cetts, or NK cetts. There is no 
difference in TNF atpha revers in BMT versus controt 
mice post infection. White IFN-gamma increased in 
controt mice, no increase was seen in BMT mice 
post infection. 
Conclusion: Mice post-BMT have an increased sus- 
ceptibitity to [ytic tung infection with MHV-68 after 
futt engraftment has occurred. This finding is tikety 
retated to both innate and adaptive immune de- 
fects. 
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Hematopoietic Stem Cell Transplant Recipients 
in Korea: The Association of gB Genotype with 
CMV Diseases? 
S-M. Choi*, S.H. Park, D-G. Lee, J-H. Choi, 
J-H. Yoo, J-A. Hur, W-S. Shin, C-Ch. Kim. 
Department of Internal Medicine, The Catholic 
Hemopoietic Stem Cell Transplantation Center, 
The Catholic University of Korea, SeouC Korea 
Background & Objectives: The cytomegalovirus 
(CMV) gtycoprotein B (gB) is the major envetope 
gtycoprotein, encoded by the UL55 gene. Based on 
sequence variation in the UL55 gene, CMV can be 
ctassified into four gB genotypes. Previous studies 
have suggested there coutd be an association be- 
tween CMV gB genotype and ctinica[ outcome in 
the immunocompromised hosts. The goat of this 
study was to determine the distribution of CMV 
gB genotypes and the effect of gB genotype in 
the devetopment of CMV diseases in hematopoietic 
stem cet[ transptant (HSCT) recipients in Korea. 
